K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α

被引:10
作者
Imam, Sabrina [1 ]
Komurlu, Sevnur [1 ]
Mattick, Jessica [1 ]
Selyutina, Anastasia [3 ]
Talley, Sarah [2 ]
Eddins, Amani [1 ]
Diaz-Griffero, Felipe [3 ]
Campbell, Edward M. [1 ,2 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA
[2] Loyola Univ Chicago, Stritch Sch Med, Integrat Cell Biol Program, Maywood, IL 60153 USA
[3] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA
关键词
deubiquitinating enzymes; HIV-1; retroviral restriction; TRIM5alpha; ubiquitination; STRUCTURAL BASIS; AUTOPHAGY; PROTEINS; BINDING; IDENTIFICATION; INFECTION; CHAINS; INTERMEDIATE; RECOGNITION; DEGRADATION;
D O I
10.1128/JVI.00558-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
TRIM5 alpha is an antiviral restriction factor that inhibits retroviral infection in a species-specific fashion. TRIM5 alpha binds to and forms assemblies around the retroviral capsid. Following binding, poorly understood, ubiquitin-dependent events lead to the disassembly of the viral core, prior to the accumulation of viral reverse transcription products in the target cell. It is also known that assemblies of TRIM5 alpha and other TRIM family proteins can be targets of autophagic degradation. The goal of this study was to define the role of specific ubiquitin linkages in the retroviral restriction and autophagic degradation of TRIM5 alpha and delineate any connection between these two processes. To this end, we generated fusion proteins in which the catalytic domains of different deubiquitinase (DUB) enzymes, with different specificities for polyubiquitinated linkages, were fused to the N-terminal RING domain of Rhesus macaque TRIM5 alpha. We assessed the role of ubiquitination in restriction and the degree to which specific types of ubiquitination are required for the association of TRIM5 alpha with autophagic proteins. We determined that K63-linked ubiquitination by TRIM5 alpha is required to induce capsid disassembly and to inhibit reverse transcription of HIV, while the ability to inhibit HIV-1 infection was not dependent on K63-linked ubiquitination. We also observed that K63-linked ubiquitination is required for the association of TRIM5 alpha with autophagosomal membranes and the autophagic adapter protein p62. IMPORTANCE Although the mechanisms by which TRIM5 alpha can induce the abortive disassembly of retroviral capsids have remained obscure, numerous studies have suggested a role for ubiquitination and cellular degradative pathways. These studies have typically relied on global perturbation of cellular degradative pathways. Here, through the use of linkage-specific deubiquitinating enzymes tethered to TRIM5 alpha, we delineate the ubiquitin linkages which drive specific steps in restriction and degradation by TRIM5 alpha, providing evidence for a noncanonical role for K63-linked ubiquitin in the process of retroviral restriction by TRIM5 alpha and potentially providing insight into the mechanism of action of other TRIM family proteins.
引用
收藏
页数:16
相关论文
共 60 条
  • [1] Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins
    Anderson, Jenny L.
    Campbell, Edward M.
    Wu, Xiaolu
    Vandegraaff, Nick
    Engelman, Alan
    Hope, Thomas J.
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (19) : 9754 - 9760
  • [2] Structural basis of HIV-1 capsid recognition by PF74 and CPSF6
    Bhattacharya, Akash
    Alam, Steven L.
    Fricke, Thomas
    Zadrozny, Kaneil
    Sedzicki, Jaroslaw
    Taylor, Alexander B.
    Demeler, Borries
    Pornillos, Owen
    Ganser-Pornillos, Barbie K.
    Diaz-Griffero, Felipe
    Ivanov, Dmitri N.
    Yeager, Mark
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (52) : 18625 - 18630
  • [3] Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5α
    Campbell, Edward M.
    Perez, Omar
    Anderson, Jenny L.
    Hope, Thomas J.
    [J]. JOURNAL OF CELL BIOLOGY, 2008, 180 (03) : 549 - 561
  • [4] TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization
    Campbell, Edward M.
    Weingart, Jared
    Sette, Paola
    Opp, Silvana
    Sastri, Jaya
    O'Connor, Sarah K.
    Talley, Sarah
    Diaz-Griffero, Felipe
    Hirsch, Vanessa
    Bouamr, Fadila
    [J]. JOURNAL OF VIROLOGY, 2016, 90 (04) : 1849 - 1857
  • [5] Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity
    Campbell, EM
    Nunez, R
    Hope, TJ
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (11) : 5745 - 5755
  • [6] Identification of a major co-receptor for primary isolates of HIV-1
    Deng, HK
    Liu, R
    Ellmeier, W
    Choe, S
    Unutmaz, D
    Burkhart, M
    DiMarzio, P
    Marmon, S
    Sutton, RE
    Hill, CM
    Davis, CB
    Peiper, SC
    Schall, TJ
    Littman, DR
    Landau, NR
    [J]. NATURE, 1996, 381 (6584) : 661 - 666
  • [7] Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1
    Diaz-Griffero, Felipe
    Vandegraaff, Nick
    Li, Yuan
    McGee-Estrada, Kathleen
    Stremlau, Matthew
    Welikala, Sohanya
    Si, Zhihai
    Engelman, Alan
    Sodroski, Joseph
    [J]. VIROLOGY, 2006, 351 (02) : 404 - 419
  • [8] A B-Box 2 Surface Patch Important for TRIM5α Self-Association, Capsid Binding Avidity, and Retrovirus Restriction
    Diaz-Griffero, Felipe
    Qin, Xu-rong
    Hayashi, Fumiaki
    Kigawa, Takanori
    Finzi, Andres
    Sarnak, Zoe
    Lienlaf, Maritza
    Yokoyama, Shigeyuki
    Sodroski, Joseph
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (20) : 10737 - 10751
  • [9] Ubiquitin enzymes in the regulation of immune responses
    Ebner, Petra
    Versteeg, Gijs A.
    Ikeda, Fumiyo
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 52 (04) : 425 - 460
  • [10] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
    Finzi, D
    Blankson, J
    Siliciano, JD
    Margolick, JB
    Chadwick, K
    Pierson, T
    Smith, K
    Lisziewicz, J
    Lori, F
    Flexner, C
    Quinn, TC
    Chaisson, RE
    Rosenberg, E
    Walker, B
    Gange, S
    Gallant, J
    Siliciano, RF
    [J]. NATURE MEDICINE, 1999, 5 (05) : 512 - 517